Table 2.
List of cell lines used in this research
| Cell line | Cancer type | Culture | Inoculation | Source |
|---|---|---|---|---|
| A431 | Epidermoid carcinoma | DMEM | 2.0 × 106 | ATCC |
| H460 | Lung large cell carcinoma | RPMI | 3.0 × 106 | ATCC |
| HPAF-II | Pancreatic ductal adenocarcinoma | EMEM | 3.0 × 106 | ATCC |
| HSC-2 | Oral cavity squamous cell carcinoma | DMEM | 5.0 × 106 | Dr. Gary S. Goldberg (Rowan University) |
| HT1376-luc | Bladder carcinoma | DMEM | 6.0 × 106 | FenicsBIO (Halethorpe, MD, USA) |
| MDAMB231 | Breast adenocarcinoma | RPMI | 10.0 × 106 | The Division of Cancer Treatment and Diagnosis Tumor Repository (NCI Frederick) |
| SKOV3-luc | Ovarian serous cystadenocarcinoma | McCoy's | 3.0 × 106 | Caliper LifeSciences (Hopkinton, MA, USA) |
DMEM, Dulbecco's modified eagle medium (ATCC, Manassas, VA, USA); EMEM, Eagle's minimum essential medium (ATCC); RPMI, RPMI1640 (Thermo fisher scientific, Rockford, IL, USA); McCoy's, McCoy's 5A medium (Thermo fisher scientific)